| Jun 20 |
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
| Jun 14 |
Ocular Therapeutix jumps after investor day updates
|
| Jun 13 |
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Study (SOL-R) in wet AMD at Investor Day, Along with Positive 48-week Data from HELIOS NPDR Study
|
| Jun 5 |
An Intrinsic Calculation For Ocular Therapeutix, Inc. (NASDAQ:OCUL) Suggests It's 45% Undervalued
|
| Jun 5 |
Ocular Therapeutix® to Host Investor Day on June 13, 2024
|
| Jun 4 |
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| Jun 3 |
Ocular Therapeutix: Betting On Axpaxli For A Major Market Breakthrough
|
| Jun 1 |
Ocular Therapeutix: Unveiling Pipeline Progress (AXPAXLI, PAXTRAVA) And Q1 Results
|
